Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

The MASK Study Group

doi:10.1111/cea.13025

Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

The MASK Study Group

Division of Immunology, Immunity to Infection and Respiratory Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Visual Analogue Scale (VAS) is a validated tool to assess control in allergic rhinitis patients. Objective: The aim of this study was to validate the use of VAS in the MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) app (Allergy Diary) on smartphones screens to evaluate allergic rhinitis symptoms and disease control. Methods: Each user filled 4 different VAS measuring overall, nasal, ocular, and asthma symptoms at least once. Following COSMIN guidelines, we evaluated internal consistency, (Cronbach's alpha coefficient and test-retest), reliability (intraclass correlation coefficients), sensitivity, and acceptability of the MASK-Rhinitis VAS. Results: Between 1 August 2015 and 31 July 2016, the app was used 14 612 times in 15 countries. A total of 1225 users used it more than once, during the evaluated period. The tool resulted to be statistically satisfactory, showing excellent internal consistency (Cronbach's test > 0.84, test-retest > 0.7), reliability (>0.9), and acceptability. In addition, the tool had a good sensitivity when users (n = 521) answered the VAS twice in less than 3 hours. Conclusions and Clinical Relevance: The MASK-rhinitis VAS is a reliable and valid tool to assess allergic control on smartphone screens, at the population level.

Original language	English
Pages (from-to)	1526-1533
Number of pages	8
Journal	Clinical and Experimental Allergy
Volume	47
Issue number	12
Early online date	8 Sept 2017
DOIs	https://doi.org/10.1111/cea.13025
Publication status	Published - 29 Nov 2017

Keywords

allergic rhinitis
allergy
control
MASK
visual analogue scale

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/cea.13025

Cite this

@article{93a95187abf042f3b0243bce66a2e11a,

title = "Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control",

abstract = "Background: Visual Analogue Scale (VAS) is a validated tool to assess control in allergic rhinitis patients. Objective: The aim of this study was to validate the use of VAS in the MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) app (Allergy Diary) on smartphones screens to evaluate allergic rhinitis symptoms and disease control. Methods: Each user filled 4 different VAS measuring overall, nasal, ocular, and asthma symptoms at least once. Following COSMIN guidelines, we evaluated internal consistency, (Cronbach's alpha coefficient and test-retest), reliability (intraclass correlation coefficients), sensitivity, and acceptability of the MASK-Rhinitis VAS. Results: Between 1 August 2015 and 31 July 2016, the app was used 14 612 times in 15 countries. A total of 1225 users used it more than once, during the evaluated period. The tool resulted to be statistically satisfactory, showing excellent internal consistency (Cronbach's test > 0.84, test-retest > 0.7), reliability (>0.9), and acceptability. In addition, the tool had a good sensitivity when users (n = 521) answered the VAS twice in less than 3 hours. Conclusions and Clinical Relevance: The MASK-rhinitis VAS is a reliable and valid tool to assess allergic control on smartphone screens, at the population level.",

keywords = "allergic rhinitis, allergy, control, MASK, visual analogue scale",

author = "{The MASK Study Group} and D. Caimmi and N. Baiz and Tanno, {L. K.} and P. Demoly and S. Arnavielhe and R. Murray and A. Bedbrook and Bergmann, {K. C.} and {De Vries}, G. and Fokkens, {W. J.} and J. Fonseca and T. Haahtela and T. Keil and P. Kuna and J. Mullol and N. Papadopoulos and G. Passalacqua and B. Samolinski and Tomazic, {P. V.} and A. Valiulis and {van Eerd}, M. and M. Wickman and I. Annesi-Maesano and J. Bousquet and I. Agache and R. Angles and Anto, {J. M.} and E. Asayag and E. Bacci and C. Bachert and I. Baroni and Barreto, {B. A.} and M. Bedolla-Barajas and L. Bertorello and M. Bewick and T. Bieber and S. Birov and C. Bindslev-Jensen and A. Blua and {Bochenska Marciniak}, M. and I. Bogus-Buczynska and S. Bosnic-Ancevich and I. Bosse and R. Bourret and C. Bucca and R. Buonaiuto and D. Caiazza and D. Caillot and Caimmi, {D. P.} and P. Camargos",

year = "2017",

month = nov,

day = "29",

doi = "10.1111/cea.13025",

language = "English",

volume = "47",

pages = "1526--1533",

journal = "Clinical and Experimental Allergy",

issn = "0954-7894",

publisher = "John Wiley & Sons Ltd",

number = "12",

}

TY - JOUR

T1 - Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

AU - The MASK Study Group

AU - Caimmi, D.

AU - Baiz, N.

AU - Tanno, L. K.

AU - Demoly, P.

AU - Arnavielhe, S.

AU - Murray, R.

AU - Bedbrook, A.

AU - Bergmann, K. C.

AU - De Vries, G.

AU - Fokkens, W. J.

AU - Fonseca, J.

AU - Haahtela, T.

AU - Keil, T.

AU - Kuna, P.

AU - Mullol, J.

AU - Papadopoulos, N.

AU - Passalacqua, G.

AU - Samolinski, B.

AU - Tomazic, P. V.

AU - Valiulis, A.

AU - van Eerd, M.

AU - Wickman, M.

AU - Annesi-Maesano, I.

AU - Bousquet, J.

AU - Agache, I.

AU - Angles, R.

AU - Anto, J. M.

AU - Asayag, E.

AU - Bacci, E.

AU - Bachert, C.

AU - Baroni, I.

AU - Barreto, B. A.

AU - Bedolla-Barajas, M.

AU - Bertorello, L.

AU - Bewick, M.

AU - Bieber, T.

AU - Birov, S.

AU - Bindslev-Jensen, C.

AU - Blua, A.

AU - Bochenska Marciniak, M.

AU - Bogus-Buczynska, I.

AU - Bosnic-Ancevich, S.

AU - Bosse, I.

AU - Bourret, R.

AU - Bucca, C.

AU - Buonaiuto, R.

AU - Caiazza, D.

AU - Caillot, D.

AU - Caimmi, D. P.

AU - Camargos, P.

PY - 2017/11/29

Y1 - 2017/11/29

N2 - Background: Visual Analogue Scale (VAS) is a validated tool to assess control in allergic rhinitis patients. Objective: The aim of this study was to validate the use of VAS in the MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) app (Allergy Diary) on smartphones screens to evaluate allergic rhinitis symptoms and disease control. Methods: Each user filled 4 different VAS measuring overall, nasal, ocular, and asthma symptoms at least once. Following COSMIN guidelines, we evaluated internal consistency, (Cronbach's alpha coefficient and test-retest), reliability (intraclass correlation coefficients), sensitivity, and acceptability of the MASK-Rhinitis VAS. Results: Between 1 August 2015 and 31 July 2016, the app was used 14 612 times in 15 countries. A total of 1225 users used it more than once, during the evaluated period. The tool resulted to be statistically satisfactory, showing excellent internal consistency (Cronbach's test > 0.84, test-retest > 0.7), reliability (>0.9), and acceptability. In addition, the tool had a good sensitivity when users (n = 521) answered the VAS twice in less than 3 hours. Conclusions and Clinical Relevance: The MASK-rhinitis VAS is a reliable and valid tool to assess allergic control on smartphone screens, at the population level.

AB - Background: Visual Analogue Scale (VAS) is a validated tool to assess control in allergic rhinitis patients. Objective: The aim of this study was to validate the use of VAS in the MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) app (Allergy Diary) on smartphones screens to evaluate allergic rhinitis symptoms and disease control. Methods: Each user filled 4 different VAS measuring overall, nasal, ocular, and asthma symptoms at least once. Following COSMIN guidelines, we evaluated internal consistency, (Cronbach's alpha coefficient and test-retest), reliability (intraclass correlation coefficients), sensitivity, and acceptability of the MASK-Rhinitis VAS. Results: Between 1 August 2015 and 31 July 2016, the app was used 14 612 times in 15 countries. A total of 1225 users used it more than once, during the evaluated period. The tool resulted to be statistically satisfactory, showing excellent internal consistency (Cronbach's test > 0.84, test-retest > 0.7), reliability (>0.9), and acceptability. In addition, the tool had a good sensitivity when users (n = 521) answered the VAS twice in less than 3 hours. Conclusions and Clinical Relevance: The MASK-rhinitis VAS is a reliable and valid tool to assess allergic control on smartphone screens, at the population level.

KW - allergic rhinitis

KW - allergy

KW - control

KW - MASK

KW - visual analogue scale

UR - http://www.scopus.com/inward/record.url?scp=85031126992&partnerID=8YFLogxK

U2 - 10.1111/cea.13025

DO - 10.1111/cea.13025

M3 - Article

C2 - 28886234

AN - SCOPUS:85031126992

SN - 0954-7894

VL - 47

SP - 1526

EP - 1533

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

IS - 12

ER -

Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this